Outcomes in randomized controlled trials of traditional Chinese medicine in treatment of diabetic kidney disease.
10.19540/j.cnki.cjcmm.20240826.502
- Author:
Yi-Jia JIANG
1
;
Mao-Ying WEI
1
;
Wen-Hua ZHANG
1
;
Dan YIN
1
;
Yi-Ting TANG
1
;
Wei-Yu JIA
1
;
Jing-Yi GUO
1
;
Ai-Jing LI
1
;
Yan-Bing GONG
2
Author Information
1. Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
2. Beijing University of Chinese Medicine Beijing 100029, China.
- Publication Type:English Abstract
- Keywords:
core outcome set;
diabetic kidney disease;
outcome indicator;
randomized controlled trial;
traditional Chinese medicine
- MeSH:
Humans;
Randomized Controlled Trials as Topic;
Diabetic Nephropathies/drug therapy*;
Drugs, Chinese Herbal/therapeutic use*;
Treatment Outcome;
Medicine, Chinese Traditional;
Quality of Life
- From:
China Journal of Chinese Materia Medica
2024;49(24):6813-6824
- CountryChina
- Language:Chinese
-
Abstract:
This study systematically analyzed the current status of outcomes in randomized controlled trial(RCT) of traditional Chinese medicine(TCM) treatment of diabetic kidney disease(DKD), aiming to provide a reference for constructing the core outcome set(COS) of TCM treatment of DKD. The clinical RCTs of TCM treatment of DKD that were published from January 2019 to March 2024 were retrieved from seven databases: CNKI, Wanfang, VIP, SinoMed, PubMed, Cochrane Library, and Web of Science. The risk of bias was assessed and outcome indicators were qualitatively analyzed. A total of 323 RCTs were included, reporting 199 outcome indicators with the frequency of 3 744 in seven indicator domains: TCM syndromes(196 times, 5.24%), symptoms and signs(275 times, 7.35%), physical and chemical examinations(2 820 times, 75.32%), safety events(422 times, 11.27%), long-term prognosis(21 times, 0.56%), quality of life(9 times, 0.24%), and economic evaluation(1 time, 0.02%). The three most frequently applied outcome indicators were total clinical response rate(268 times, 82.97%), serum creatinine(251 times, 77.71%), and urea nitrogen(206 times, 63.78%). The outcomes in the studies of TCM treatment of DKD had the limitations of high risk of bias, lack of standardization of TCM syndromes and efficacy evaluation, neglect of endpoint indicators, large differences in endpoint indicators and time points of measurement, unclear primary and secondary outcomes, few application of long-term prognosis, quality of life, and economic indicators, and insufficient reporting of safety events. In the future, efforts should be made to actively promote the construction of COS in the studies about the TCM treatment of DKD and enhance the quality of the clinical studies.
